Company intelligence / Profile preview

Zura Bio

San Diego, California, United Stateszurabio.com ↗
Ownership
Public · ZURA
Employees
~30
Development stage
Phase 2
01

Overview

Zura Bio develops novel dual-pathway monoclonal antibody therapies for serious immune system disorders. Its lead asset tibulizumab has entered a global Phase 2 trial for systemic sclerosis, while torudokimab and crebankitug have completed early clinical studies with promising safety profiles. The company’s approach aims to address unmet needs in complex autoimmune diseases by targeting multiple immune pathways simultaneously.

Therapeutic areas
ImmunologyDermatologyRheumatologyEndocrinology
Modalities
Monoclonal antibodies (mAbs)Bispecific antibodies
Industry
Biotech
02

Drug pipeline

3 assets

tibulizumab

3

2 more assets in the full pipeline.

03

Partnerships

In‐licensed crebankitug from PfizerIn‐licensed torudokimab and tibulizumab from Eli LillySponsorship agreement with Benaroya Research Institute
04

Financials

Market cap
$358.3M
Total revenue
$0
Enterprise value
$170.7M

Beyond the preview

Go deeper on Zura Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zura Bio.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call